CA2471994A1 - Hemostatic compositions and methods for controlling bleeding - Google Patents
Hemostatic compositions and methods for controlling bleeding Download PDFInfo
- Publication number
- CA2471994A1 CA2471994A1 CA002471994A CA2471994A CA2471994A1 CA 2471994 A1 CA2471994 A1 CA 2471994A1 CA 002471994 A CA002471994 A CA 002471994A CA 2471994 A CA2471994 A CA 2471994A CA 2471994 A1 CA2471994 A1 CA 2471994A1
- Authority
- CA
- Canada
- Prior art keywords
- dextran
- polysaccharide
- linked
- cellulose
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 179
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 128
- 238000000034 method Methods 0.000 title claims abstract description 128
- 230000000740 bleeding effect Effects 0.000 title claims abstract description 51
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 166
- 239000005017 polysaccharide Substances 0.000 claims abstract description 166
- 229920002678 cellulose Polymers 0.000 claims abstract description 93
- 239000001913 cellulose Substances 0.000 claims abstract description 92
- 229920000742 Cotton Polymers 0.000 claims abstract description 24
- -1 e.g. Polymers 0.000 claims abstract description 16
- 150000004676 glycans Chemical group 0.000 claims abstract 40
- 229920002307 Dextran Polymers 0.000 claims description 152
- 235000010980 cellulose Nutrition 0.000 claims description 91
- 239000000243 solution Substances 0.000 claims description 82
- 229920000615 alginic acid Polymers 0.000 claims description 70
- 229940072056 alginate Drugs 0.000 claims description 64
- 239000003795 chemical substances by application Substances 0.000 claims description 47
- 229910001424 calcium ion Inorganic materials 0.000 claims description 40
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical group ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 39
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 38
- 235000010443 alginic acid Nutrition 0.000 claims description 28
- 239000011324 bead Substances 0.000 claims description 27
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 23
- 235000010413 sodium alginate Nutrition 0.000 claims description 23
- 239000000661 sodium alginate Substances 0.000 claims description 23
- 229940005550 sodium alginate Drugs 0.000 claims description 23
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 22
- 239000003381 stabilizer Substances 0.000 claims description 16
- 150000001768 cations Chemical class 0.000 claims description 15
- 239000012670 alkaline solution Substances 0.000 claims description 14
- 230000007717 exclusion Effects 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 230000000087 stabilizing effect Effects 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 9
- 239000012074 organic phase Substances 0.000 claims description 8
- 102000009123 Fibrin Human genes 0.000 claims description 6
- 108010073385 Fibrin Proteins 0.000 claims description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 6
- 229950003499 fibrin Drugs 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 108010049003 Fibrinogen Proteins 0.000 claims description 5
- 102000008946 Fibrinogen Human genes 0.000 claims description 5
- 239000003431 cross linking reagent Substances 0.000 claims description 5
- 229940012952 fibrinogen Drugs 0.000 claims description 5
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims description 4
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000003114 blood coagulation factor Substances 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 3
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 3
- 229940035676 analgesics Drugs 0.000 claims description 3
- 229940035674 anesthetics Drugs 0.000 claims description 3
- 239000000730 antalgic agent Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 229940030225 antihemorrhagics Drugs 0.000 claims description 3
- 239000000739 antihistaminic agent Substances 0.000 claims description 3
- 229940125715 antihistaminic agent Drugs 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 239000003899 bactericide agent Substances 0.000 claims description 3
- 229940044683 chemotherapy drug Drugs 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 229960005188 collagen Drugs 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000000417 fungicide Substances 0.000 claims description 3
- 239000003193 general anesthetic agent Substances 0.000 claims description 3
- 239000002874 hemostatic agent Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 150000003431 steroids Chemical class 0.000 claims description 3
- 239000005526 vasoconstrictor agent Substances 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 2
- 102000008072 Lymphokines Human genes 0.000 claims description 2
- 108010074338 Lymphokines Proteins 0.000 claims description 2
- 229940116977 epidermal growth factor Drugs 0.000 claims description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 229940124091 Keratolytic Drugs 0.000 claims 1
- 230000001530 keratinolytic effect Effects 0.000 claims 1
- 239000003410 keratolytic agent Substances 0.000 claims 1
- 230000023597 hemostasis Effects 0.000 abstract description 9
- 150000004804 polysaccharides Chemical group 0.000 description 126
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 48
- 208000032843 Hemorrhage Diseases 0.000 description 42
- 206010052428 Wound Diseases 0.000 description 33
- 208000027418 Wounds and injury Diseases 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 235000019441 ethanol Nutrition 0.000 description 25
- 150000003839 salts Chemical class 0.000 description 14
- 238000011534 incubation Methods 0.000 description 13
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 239000008194 pharmaceutical composition Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000001110 calcium chloride Substances 0.000 description 8
- 229910001628 calcium chloride Inorganic materials 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 229920005654 Sephadex Polymers 0.000 description 7
- 230000015271 coagulation Effects 0.000 description 7
- 238000005345 coagulation Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 238000001574 biopsy Methods 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 229960001126 alginic acid Drugs 0.000 description 5
- 239000000783 alginic acid Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000002523 gelfiltration Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004890 malting Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 235000010410 calcium alginate Nutrition 0.000 description 3
- 239000000648 calcium alginate Substances 0.000 description 3
- 229960002681 calcium alginate Drugs 0.000 description 3
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000010030 laminating Methods 0.000 description 3
- 238000013188 needle biopsy Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010094028 Prothrombin Proteins 0.000 description 2
- 102100027378 Prothrombin Human genes 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940039716 prothrombin Drugs 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- JDXQWYKOKYUQDN-UHFFFAOYSA-N 3-hydroxypyrrolidine-2,5-dione Chemical class OC1CC(=O)NC1=O JDXQWYKOKYUQDN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102100022641 Coagulation factor IX Human genes 0.000 description 1
- 102100023804 Coagulation factor VII Human genes 0.000 description 1
- 108010076282 Factor IX Proteins 0.000 description 1
- 108010014172 Factor V Proteins 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 108010074864 Factor XI Proteins 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 102000000429 Factor XII Human genes 0.000 description 1
- 108010071289 Factor XIII Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010000487 High-Molecular-Weight Kininogen Proteins 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 108090000113 Plasma Kallikrein Proteins 0.000 description 1
- 102100034869 Plasma kallikrein Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960004222 factor ix Drugs 0.000 description 1
- 229940012413 factor vii Drugs 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- 229940012444 factor xiii Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34324701P | 2001-12-31 | 2001-12-31 | |
| US60/343,247 | 2001-12-31 | ||
| US35491702P | 2002-02-11 | 2002-02-11 | |
| US60/354,917 | 2002-02-11 | ||
| PCT/US2002/041748 WO2003057072A2 (en) | 2001-12-31 | 2002-12-31 | Hemostatic compositions and methods for controlling bleeding |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2471994A1 true CA2471994A1 (en) | 2003-07-17 |
Family
ID=26993389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002471994A Abandoned CA2471994A1 (en) | 2001-12-31 | 2002-12-31 | Hemostatic compositions and methods for controlling bleeding |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7101862B2 (enExample) |
| EP (1) | EP1469865A4 (enExample) |
| JP (1) | JP2005514105A (enExample) |
| AU (1) | AU2002361902A1 (enExample) |
| CA (1) | CA2471994A1 (enExample) |
| MX (1) | MXPA04006438A (enExample) |
| WO (1) | WO2003057072A2 (enExample) |
Families Citing this family (108)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350628A1 (en) * | 1998-11-12 | 2000-05-18 | Polymer Biosciences, Inc. | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| US20070009586A1 (en) * | 2000-02-29 | 2007-01-11 | Cohen Kelman I | Wound dressings containing complexes of transition metals and alginate for elastase sequestering |
| US6891077B2 (en) * | 2001-07-25 | 2005-05-10 | The United States Of America As Represented By The Secretary Of The Army | Fibrinogen bandages and arterial bleeding models and methods of making and using thereof |
| US7670623B2 (en) | 2002-05-31 | 2010-03-02 | Materials Modification, Inc. | Hemostatic composition |
| US7560160B2 (en) | 2002-11-25 | 2009-07-14 | Materials Modification, Inc. | Multifunctional particulate material, fluid, and composition |
| EP1663090A4 (en) | 2003-09-12 | 2010-07-21 | Z Medica Corp | HEMOSTATIC AGENT OF CALCIUM ZEOLITE |
| WO2005027834A2 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Partially hydrated hemostatic agent |
| US7448389B1 (en) | 2003-10-10 | 2008-11-11 | Materials Modification, Inc. | Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid |
| US20050136773A1 (en) * | 2003-12-22 | 2005-06-23 | Kimberly-Clark Worldwide, Inc. | Treated nonwoven material |
| US7737214B2 (en) * | 2004-03-15 | 2010-06-15 | Terumo Kabushiki Kaisha | Adhesion preventive material |
| SE0403070D0 (sv) * | 2004-12-16 | 2004-12-16 | Radi Medical Systems | Closure Device |
| US20060178609A1 (en) | 2005-02-09 | 2006-08-10 | Z-Medica, Llc | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
| KR20070117589A (ko) | 2005-02-15 | 2007-12-12 | 버지니아 커먼웰스 유니버시티 | 급성 지혈 및 급성 상처와 만성 궤양의 치료를 위한 광물기술 |
| US9326995B2 (en) | 2005-04-04 | 2016-05-03 | The Regents Of The University Of California | Oxides for wound healing and body repair |
| US20060282046A1 (en) * | 2005-04-13 | 2006-12-14 | Horn Jeffrey L | Device and method for subcutaneous delivery of blood clotting agent |
| EP1741453A3 (en) | 2005-07-07 | 2007-01-17 | Nipro Corporation | Collagen substrate, method of manufacturing the same, and method of using the same |
| DK2347775T3 (da) | 2005-12-13 | 2020-07-13 | Harvard College | Skabeloner til celletransplantation |
| GB2433205A (en) * | 2005-12-16 | 2007-06-20 | Ethicon Inc | Wound dressing comprising a strong cation exchange resin |
| US20070248653A1 (en) * | 2006-04-20 | 2007-10-25 | Cochrum Kent C | Hemostatic compositions and methods for controlling bleeding |
| US8938898B2 (en) | 2006-04-27 | 2015-01-27 | Z-Medica, Llc | Devices for the identification of medical products |
| US20070276308A1 (en) * | 2006-05-26 | 2007-11-29 | Huey Raymond J | Hemostatic agents and devices for the delivery thereof |
| US7604819B2 (en) | 2006-05-26 | 2009-10-20 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US7968114B2 (en) | 2006-05-26 | 2011-06-28 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US8202532B2 (en) | 2006-05-26 | 2012-06-19 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
| US20080014251A1 (en) * | 2006-07-14 | 2008-01-17 | Advanced Vascular Dynamics | Hemostatic compound and its use |
| US8623842B2 (en) | 2006-09-27 | 2014-01-07 | Hemostasis, Llc | Hemostatic agent and method |
| CN100453122C (zh) * | 2006-09-29 | 2009-01-21 | 沈晶 | 一种止血微粒及其制法 |
| US8414550B2 (en) | 2006-09-29 | 2013-04-09 | Lexion Medical, Llc | System and method to vent gas from a body cavity |
| US8551139B2 (en) | 2006-11-30 | 2013-10-08 | Cook Medical Technologies Llc | Visceral anchors for purse-string closure of perforations |
| EP2150183B1 (en) | 2007-05-31 | 2013-03-20 | Cook Medical Technologies LLC | Suture lock |
| US9770535B2 (en) | 2007-06-21 | 2017-09-26 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
| CN101485897B (zh) | 2008-01-14 | 2015-05-20 | 纪欣 | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 |
| US20090162406A1 (en) * | 2007-09-05 | 2009-06-25 | Z-Medica Corporation | Wound healing with zeolite-based hemostatic devices |
| US8673354B2 (en) * | 2007-11-05 | 2014-03-18 | Technion Research And Development Foundation Ltd. | Adhesives and methods of applying the same |
| CA2709337A1 (en) * | 2007-12-20 | 2009-07-02 | The University Of Queensland | Haemostasis- modulating compositions and uses therefor |
| WO2009102787A2 (en) * | 2008-02-12 | 2009-08-20 | Boston Scientific Scimed, Inc. | Medical implants with polysaccharide drug eluting coatings |
| EP2254602B1 (en) | 2008-02-13 | 2018-11-21 | President and Fellows of Harvard College | Continuous cell programming devices |
| US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
| US8585646B2 (en) | 2008-03-03 | 2013-11-19 | Lexion Medical, Llc | System and method to vent gas from a body cavity |
| US9061087B2 (en) * | 2008-03-04 | 2015-06-23 | Hemostasis, Llc | Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor |
| US8828358B2 (en) * | 2008-03-11 | 2014-09-09 | Materials Modifications, Inc. | In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| US8852558B2 (en) * | 2008-03-11 | 2014-10-07 | Materials Modification, Inc. | In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst |
| US10046081B2 (en) | 2008-04-11 | 2018-08-14 | The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. | Electrospun dextran fibers and devices formed therefrom |
| EP2276879B1 (en) | 2008-04-11 | 2015-11-25 | Virginia Commonwealth University | Electrospun dextran fibers and devices formed therefrom |
| US20090275904A1 (en) * | 2008-05-02 | 2009-11-05 | Sardesai Neil Rajendra | Sheet assemblies with releasable medicaments |
| WO2009137438A2 (en) | 2008-05-06 | 2009-11-12 | Wilson-Cook Medical Inc. | Apparatus and methods for delivering therapeutic agents |
| US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
| US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
| US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
| US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
| US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
| EP2349012B1 (en) * | 2008-10-29 | 2014-11-19 | Cook Medical Technologies LLC | Endoscopic sheet delivery |
| EP2384147B1 (en) * | 2008-12-11 | 2014-08-13 | Cook Medical Technologies LLC | Endoscopic sheet rolling system |
| AU2009330505A1 (en) | 2008-12-23 | 2011-06-30 | Cook Medical Technologies Llc | Apparatus and methods for containing and delivering therapeutic agents |
| WO2010115072A1 (en) | 2009-04-03 | 2010-10-07 | Wilson-Cook Medical, Inc. | Tissue anchors and medical devices for rapid deployment of tissue anchors |
| WO2010120749A2 (en) | 2009-04-13 | 2010-10-21 | President And Fellow Of Harvard College | Harnessing cell dynamics to engineer materials |
| CA2761903C (en) | 2009-05-28 | 2018-04-10 | Profibrix B.V. | Dry powder fibrin sealant |
| US9101744B2 (en) | 2009-05-29 | 2015-08-11 | Cook Medical Technologies Llc | Systems and methods for delivering therapeutic agents |
| US8118777B2 (en) * | 2009-05-29 | 2012-02-21 | Cook Medical Technologies Llc | Systems and methods for delivering therapeutic agents |
| CN102497890B (zh) * | 2009-06-01 | 2014-08-27 | 特克尼雍技术研究与发展基金会有限公司 | 密封材料、其制造和施加其方法 |
| US8728456B2 (en) | 2009-07-31 | 2014-05-20 | President And Fellows Of Harvard College | Programming of cells for tolerogenic therapies |
| US20110052663A1 (en) * | 2009-09-01 | 2011-03-03 | Hemostasis, Llc | Hemostatic Sponge with Enzyme and Method of Manufacture |
| EP2542230A4 (en) | 2010-03-05 | 2013-08-28 | Harvard College | PROMOTING THE ADHESION OF SKELETAL MUSCLE STEM CELLS BY SIMULTANEOUS ADMINISTRATION OF VEGF AND IGF-1 |
| US20110237994A1 (en) * | 2010-03-25 | 2011-09-29 | Combat Medical Systems, Llc | Void-filling wound dressing |
| US9693954B2 (en) | 2010-06-25 | 2017-07-04 | President And Fellows Of Harvard College | Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| US8858969B2 (en) | 2010-09-22 | 2014-10-14 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
| PL2624873T3 (pl) | 2010-10-06 | 2020-12-14 | President And Fellows Of Harvard College | Nadające się do wstrzykiwania hydrożele tworzące pory do terapii komórkowych opartych na materiałach |
| WO2012057751A1 (en) * | 2010-10-27 | 2012-05-03 | Empire Technology Development Llc | Crosslinked cellulosic polymers |
| US9603894B2 (en) | 2010-11-08 | 2017-03-28 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
| EP2701753B1 (en) | 2011-04-27 | 2018-12-26 | President and Fellows of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
| ES2685327T3 (es) | 2011-04-28 | 2018-10-08 | President And Fellows Of Harvard College | Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| JP6062426B2 (ja) | 2011-06-03 | 2017-01-18 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | インサイチュー抗原生成癌ワクチン |
| WO2013025685A1 (en) | 2011-08-14 | 2013-02-21 | Materials Modification, Inc. | Method and composition for in situ formation of an artificial blockage to control blood loss |
| WO2013052577A1 (en) * | 2011-10-04 | 2013-04-11 | Z-Medica, Llc | Hemostatic fibrous material |
| US9597425B2 (en) | 2011-10-18 | 2017-03-21 | St. Teresa Medical, Inc. | Method of forming a hemostatic product |
| CN102551896B (zh) * | 2012-01-19 | 2013-08-07 | 河南科技大学 | 一次性计数脑棉无菌包装托盘 |
| PL2838515T3 (pl) | 2012-04-16 | 2020-06-29 | President And Fellows Of Harvard College | Kompozycje mezoporowatego krzemu do modulowania odpowiedzi odpornościowych |
| KR101945031B1 (ko) * | 2012-06-22 | 2019-02-01 | 지-메디카 엘엘씨 | 지혈 장치 |
| US9649330B2 (en) * | 2013-01-17 | 2017-05-16 | Thomas Barrows | Hydrogel tattoo protection and aftercare system |
| US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
| US9867931B2 (en) | 2013-10-02 | 2018-01-16 | Cook Medical Technologies Llc | Therapeutic agents for delivery using a catheter and pressure source |
| US10016524B2 (en) * | 2013-04-11 | 2018-07-10 | President And Fellows Of Harvard College | Prefabricated alginate-drug bandages |
| GB2514592A (en) * | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
| CA2922991A1 (en) | 2013-11-12 | 2015-05-21 | St. Teresa Medical, Inc. | Hemostatic products |
| CN107073090A (zh) | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
| CN106470703B (zh) | 2014-05-05 | 2022-01-11 | 先进医疗解决方案以色列(西兰迪斯)公司 | 生物粘连剂和密封剂以及其使用方法 |
| US10137219B2 (en) | 2014-08-04 | 2018-11-27 | James F. Drake | Coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating |
| WO2016123573A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
| JP7094533B2 (ja) | 2015-04-10 | 2022-07-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫細胞捕捉デバイスおよびその製造および使用方法 |
| KR102641229B1 (ko) * | 2015-09-01 | 2024-02-29 | 백스터 인터내셔널 인코포레이티드 | 지혈 물질 |
| US10137221B2 (en) | 2015-11-08 | 2018-11-27 | Omrix Biopharmaceuticals Ltd. | Hemostatic mixture of cellulose-based short and long fibers |
| EP3373853A4 (en) | 2015-11-12 | 2019-07-10 | St. Teresa Medical, Inc. | METHOD FOR SEALING A DUROTOMY |
| US11752238B2 (en) | 2016-02-06 | 2023-09-12 | President And Fellows Of Harvard College | Recapitulating the hematopoietic niche to reconstitute immunity |
| JP2019522486A (ja) | 2016-07-13 | 2019-08-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 抗原提示細胞模倣足場およびそれを作製および使用するための方法 |
| KR102638898B1 (ko) | 2016-08-02 | 2024-02-22 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 면역 반응을 조정하기 위한 생체재료 |
| US20180099069A1 (en) * | 2016-10-11 | 2018-04-12 | St. Teresa Medical, Inc. | Hemostatic products |
| WO2018075279A1 (en) * | 2016-10-20 | 2018-04-26 | Bard Access Systems, Inc. | Antimicrobial alginate-based microparticles and related materials and methods |
| US10953130B2 (en) | 2017-08-31 | 2021-03-23 | Victor Matthew Phillips | Solid hemostatic composition and methods of making the same |
| WO2019089717A1 (en) | 2017-11-02 | 2019-05-09 | St. Teresa Medical, Inc. | Fibrin sealant products |
| EP3717028A1 (en) * | 2017-11-28 | 2020-10-07 | Baxter International Inc | Wound-treating absorbent |
| CN108144128B (zh) * | 2018-02-07 | 2021-11-05 | 陕西佰傲再生医学有限公司 | 一种多次交联乳房补片及其制备方法 |
| CN109125790A (zh) * | 2018-08-25 | 2019-01-04 | 山东康力医疗器械科技有限公司 | 一种采用壳聚糖制作的止血海绵结构 |
| WO2020061129A1 (en) | 2018-09-19 | 2020-03-26 | President And Fellows Of Harvard College | Compositions and methods for labeling and modulation of cells in vitro and in vivo |
| WO2021247850A2 (en) | 2020-06-05 | 2021-12-09 | Cook Medical Technologies Llc | Medical scopes for delivering therapeutic agents |
| JP2023092390A (ja) * | 2021-12-21 | 2023-07-03 | 富士フイルム株式会社 | 止血材組成物 |
| JP2023092391A (ja) * | 2021-12-21 | 2023-07-03 | 富士フイルム株式会社 | 止血材組成物 |
| US12496429B2 (en) | 2022-10-18 | 2025-12-16 | Cook Medical Technologies Llc | Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents |
Family Cites Families (123)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US27327A (en) * | 1860-02-28 | Improvement in apparatus for distilling coal-oil | ||
| US854715A (en) * | 1905-10-26 | 1907-05-28 | Gen Electric | Combined coupling and bearing. |
| US959080A (en) * | 1908-08-05 | 1910-05-24 | Samuel B Sheldon | Process for coking coal. |
| US974054A (en) * | 1910-01-20 | 1910-10-25 | Frank Guy | Acetylene-lamp. |
| US1454055A (en) * | 1920-04-17 | 1923-05-08 | Klamroth Wilfried | Razor-blade holder |
| US2387642A (en) | 1942-03-25 | 1945-10-23 | Calhoun Vernon | Hemostat and method of forming same |
| SE169293C1 (enExample) | 1958-03-13 | 1959-11-10 | ||
| GB942305A (en) | 1958-12-23 | 1963-11-20 | Parachem Corp | Improvements in or relating to antiseptic film and method and apparatus for producing the same |
| NL262878A (enExample) | 1960-03-28 | |||
| SE358894B (enExample) | 1961-10-25 | 1973-08-13 | Pharmacia Ab | |
| US3206361A (en) | 1962-06-19 | 1965-09-14 | Johnson & Johnson | Stabilized methylaminoacetocatechol hemostatic wound dressing |
| US3507851A (en) | 1966-03-24 | 1970-04-21 | Victor Ghetie | Synthesis derivatives of agarose having application in electrophoresis on gel and in chromatography |
| US3671280A (en) * | 1970-12-04 | 1972-06-20 | David F Smith | Plaster of paris bandages to make casts of improved strength,water-resistance and physiological properties |
| DE2247163A1 (de) | 1972-09-26 | 1974-03-28 | Merck Patent Gmbh | Traegermatrix zur fixierung biologisch wirksamer stoffe und verfahren zu ihrer herstellung |
| US3810473A (en) | 1972-12-04 | 1974-05-14 | Avicon Inc | Liquid-laid, non-woven, fibrous collagen derived surgical web having hemostatic and wound sealing properties |
| SE452109B (sv) | 1973-01-29 | 1987-11-16 | Pharmacia Ab | Rengoringsmedel for vetskande utvertes sarytor |
| FR2234311B1 (enExample) | 1973-06-21 | 1976-04-30 | Air Liquide | |
| DE2644678A1 (de) | 1976-10-02 | 1978-04-06 | Dynamit Nobel Ag | Verfahren zur herstellung funktionalisierter cellulosen |
| US4175183A (en) | 1977-03-01 | 1979-11-20 | Development Finance Corporation Of New Zealand | Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof |
| GB1594389A (en) | 1977-06-03 | 1981-07-30 | Max Planck Gesellschaft | Dressing material for wounds |
| AT359652B (de) | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
| AT359653B (de) | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
| DE3036033A1 (de) | 1980-09-24 | 1982-05-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
| US4793336A (en) | 1981-03-25 | 1988-12-27 | Wang Paul Y | Wound coverings and processes for their preparation |
| ATE13810T1 (de) | 1981-06-25 | 1985-07-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung. |
| US4405324A (en) | 1981-08-24 | 1983-09-20 | Morca, Inc. | Absorbent cellulosic structures |
| EP0075791B1 (de) | 1981-09-30 | 1986-04-09 | VEB Leipziger Arzneimittelwerk | Absorbierender Wundverband und Verfahren zu seiner Herstellung |
| SE430218B (sv) | 1981-12-30 | 1983-10-31 | Blombaeck E G B | Filter och sett att framstella ett sadant |
| GB2118482B (en) | 1982-04-17 | 1985-11-27 | Tetsuya Nishino | Pulp fiber structure |
| US4543410A (en) | 1982-06-21 | 1985-09-24 | Morca, Inc. | Absorbent cellulosic base structures |
| US5059654A (en) | 1983-02-14 | 1991-10-22 | Cuno Inc. | Affinity matrices of modified polysaccharide supports |
| SE437270B (sv) | 1983-07-19 | 1985-02-18 | Pharmacia Ab | Separationsmaterial av tverbunden agaros och dess framstellning separationsmaterial av tverbunden agaros och dess framstellning |
| US4549653A (en) | 1983-09-06 | 1985-10-29 | Johnson & Johnson Products, Inc. | Adhesive bandage and package |
| SE460017B (sv) | 1984-03-14 | 1989-09-04 | Landstingens Inkopscentral | Bakterieadsorberande komposition i vattenoloeslig form |
| US4738849A (en) | 1984-06-28 | 1988-04-19 | Interface Biomedical Laboratories Corp. | Composite medical articles for application to wounds and method for producing same |
| US4626253A (en) | 1984-10-05 | 1986-12-02 | Johnson & Johnson Products, Inc. | Surgical hemostat comprising oxidized cellulose |
| JPS61122222A (ja) | 1984-11-19 | 1986-06-10 | Koken:Kk | コラ−ゲン又はゼラチンとプロタミンとよりなる止血剤 |
| NO166836C (no) | 1985-03-14 | 1991-09-11 | Univ California | Fremgangsmaate for behandling av et organtransplantat. |
| SE458525B (sv) | 1985-05-23 | 1989-04-10 | Pharmacia Ab | Foerfarande foer tvaerbindning av en poroes agar- eller agarosgel |
| US4616644A (en) | 1985-06-14 | 1986-10-14 | Johnson & Johnson Products, Inc. | Hemostatic adhesive bandage |
| US4946953A (en) | 1986-10-16 | 1990-08-07 | Kanebo, Ltd. | Fine cellulose particles and process for production thereof employing coagulated viscose |
| US5225047A (en) | 1987-01-20 | 1993-07-06 | Weyerhaeuser Company | Crosslinked cellulose products and method for their preparation |
| US4777249A (en) | 1987-03-13 | 1988-10-11 | Teepak, Inc. | Crosslinked cellulose aminomethanate |
| GB8705985D0 (en) | 1987-03-13 | 1987-04-15 | Geistlich Soehne Ag | Dressings |
| GB8709498D0 (en) | 1987-04-22 | 1987-05-28 | Bay M | Wound dressing |
| HU201683B (en) | 1987-08-04 | 1990-12-28 | Biogal Gyogyszergyar | Process for producing pharmaceutical compositions for promoting healing of wounds |
| US4848329A (en) * | 1987-09-01 | 1989-07-18 | Herbert Dardik | Mucoid absorbing dressing |
| JPH06104116B2 (ja) | 1988-11-29 | 1994-12-21 | 三菱化成株式会社 | 創傷被覆材 |
| US5077210A (en) | 1989-01-13 | 1991-12-31 | Eigler Frances S | Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent |
| US5015476A (en) | 1989-08-11 | 1991-05-14 | Paravax, Inc. | Immunization implant and method |
| US5185001A (en) | 1990-01-18 | 1993-02-09 | The Research Foundation Of State University Of New York | Method of preparing autologous plasma fibrin and application apparatus therefor |
| US5081041A (en) * | 1990-04-03 | 1992-01-14 | Minnesota Mining And Manufacturing Company | Ionic component sensor and method for making and using same |
| US5098417A (en) | 1990-04-12 | 1992-03-24 | Ricoh Kyosan, Inc. | Cellulosic wound dressing with an active agent ionically absorbed thereon |
| US5241009A (en) | 1990-05-07 | 1993-08-31 | Kimberly-Clark Corporation | Polymeric composition containing carboxy nueutralized with lithium or potassium |
| NO171069C (no) | 1990-05-29 | 1993-01-20 | Protan Biopolymer As | Kovalent tverrbundne, sterkt svellende alkalimetall- og ammonium-alginatgeler, samt fremgangsmaate for fremstilling derav |
| US5196190A (en) | 1990-10-03 | 1993-03-23 | Zenith Technology Corporation, Limited | Synthetic skin substitutes |
| US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| US6117425A (en) | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
| US5279955A (en) | 1991-03-01 | 1994-01-18 | Pegg Randall K | Heterofunctional crosslinking agent for immobilizing reagents on plastic substrates |
| US5690610A (en) | 1991-03-04 | 1997-11-25 | Nichiban Co., Ltd. | Adhesive material for hemostasis and a method for hemostasis |
| FR2679573B1 (fr) | 1991-07-25 | 1993-09-24 | Perfojet Sa | Procede pour la fabrication d'une nappe non tissee lavable a base de coton, et nappe ainsi obtenue. |
| US5804213A (en) | 1991-10-09 | 1998-09-08 | Lectec Corporation | Biologically active aqueous gel wound dressing |
| US5584827A (en) | 1992-05-18 | 1996-12-17 | Ultracell Medical Technologies, Inc | Nasal-packing article |
| WO1994013266A1 (en) | 1992-05-29 | 1994-06-23 | The Regents Of The University Of California | Novel electrostatic process for manufacturing coated transplants and products |
| US6001387A (en) | 1992-05-29 | 1999-12-14 | The Reguents Of The University Of California | Spin disk encapsulation apparatus and method of use |
| US5643594A (en) | 1992-05-29 | 1997-07-01 | The Regents Of The University Of California | Spin encapsulation apparatus and method of use |
| US5578314A (en) | 1992-05-29 | 1996-11-26 | The Regents Of The University Of California | Multiple layer alginate coatings of biological tissue for transplantation |
| EP0641183B1 (en) | 1992-05-29 | 2001-10-31 | The Regents Of The University Of California | Coated transplant and method for making same |
| US5429821A (en) | 1992-05-29 | 1995-07-04 | The Regents Of The University Of California | Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use |
| US5521079A (en) | 1994-01-24 | 1996-05-28 | The Regents Of The University Of California | Microcapsule generating system containing an air knife and method of encapsulating |
| US5470576A (en) * | 1992-06-08 | 1995-11-28 | The Kendall Company | Process for preparing the alginate-containing wound dressing |
| CN1091315A (zh) | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
| WO1994009831A1 (fr) | 1992-11-02 | 1994-05-11 | Nippon Meat Packers, Inc. | Matiere hemostatique a absorption topique |
| GB9225581D0 (en) | 1992-12-08 | 1993-01-27 | Courtaulds Plc | Wound dressings |
| US5330974A (en) | 1993-03-01 | 1994-07-19 | Fibratek, Inc. | Therapeutic fibrinogen compositions |
| GB2275686B (en) * | 1993-03-03 | 1997-04-30 | Johnson & Johnson Medical | Swellable wound dressing materials |
| US5681579A (en) | 1993-03-22 | 1997-10-28 | E.R. Squibb & Sons, Inc. | Polymeric support wound dressing |
| US5328687A (en) | 1993-03-31 | 1994-07-12 | Tri-Point Medical L.P. | Biocompatible monomer and polymer compositions |
| US5624669A (en) | 1993-03-31 | 1997-04-29 | Tri-Point Medical Corporation | Method of hemostatic sealing of blood vessels and internal organs |
| ES2227542T3 (es) | 1993-11-03 | 2005-04-01 | Clarion Pharmaceuticals, Inc. | Parche hemostatico. |
| US5876742A (en) * | 1994-01-24 | 1999-03-02 | The Regents Of The University Of California | Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof |
| US5502092A (en) | 1994-02-18 | 1996-03-26 | Minnesota Mining And Manufacturing Company | Biocompatible porous matrix of bioabsorbable material |
| US5406671A (en) | 1994-02-25 | 1995-04-18 | Green; Daniel K. | Trowel |
| US5514377A (en) | 1994-03-08 | 1996-05-07 | The Regents Of The University Of California | In situ dissolution of alginate coatings of biological tissue transplants |
| EP0712635B1 (en) | 1994-05-13 | 2003-05-02 | Kuraray Co., Ltd. | Medical polymer gel |
| US5502042A (en) | 1994-07-22 | 1996-03-26 | United States Surgical Corporation | Methods and compositions for treating wounds |
| US5902877A (en) * | 1994-09-21 | 1999-05-11 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Adsorbent of interleukins, process for removing the same, and adsorber for the same |
| US5585007A (en) | 1994-12-07 | 1996-12-17 | Plasmaseal Corporation | Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant |
| US5510102A (en) | 1995-01-23 | 1996-04-23 | The Regents Of The University Of California | Plasma and polymer containing surgical hemostatic adhesives |
| US5614204A (en) | 1995-01-23 | 1997-03-25 | The Regents Of The University Of California | Angiographic vascular occlusion agents and a method for hemostatic occlusion |
| US5733545A (en) | 1995-03-03 | 1998-03-31 | Quantic Biomedical Partners | Platelet glue wound sealant |
| US5900245A (en) | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
| US5795581A (en) | 1995-03-31 | 1998-08-18 | Sandia Corporation | Controlled release of molecular components of dendrimer/bioactive complexes |
| US5643192A (en) | 1995-04-06 | 1997-07-01 | Hamilton Civic Hospitals Research Development, Inc. | Autologous fibrin glue and methods for its preparation and use |
| US5795570A (en) | 1995-04-07 | 1998-08-18 | Emory University | Method of containing core material in microcapsules |
| AU5564996A (en) | 1995-04-19 | 1996-11-07 | St. Jude Medical Inc. | Matrix substrate for a viable body tissue-derived prosthesis and method for making the same |
| DE19521324C1 (de) | 1995-06-12 | 1996-10-31 | Immuno Ag | Gewebeklebstoff und Verwendung desselben als Hämostyptikum |
| US6121508A (en) * | 1995-12-29 | 2000-09-19 | 3M Innovative Properties Company | Polar, lipophilic pressure-sensitive adhesive compositions and medical devices using same |
| US5800372A (en) | 1996-01-09 | 1998-09-01 | Aerojet-General Corporation | Field dressing for control of exsanguination |
| US5696101A (en) | 1996-04-16 | 1997-12-09 | Eastman Chemical Company | Oxidized cellulose and vitamin E blend for topical hemostatic applications |
| US5945399A (en) | 1996-05-23 | 1999-08-31 | Xoma Corporation | Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| US5811151A (en) | 1996-05-31 | 1998-09-22 | Medtronic, Inc. | Method of modifying the surface of a medical device |
| US6706690B2 (en) * | 1999-06-10 | 2004-03-16 | Baxter Healthcare Corporation | Hemoactive compositions and methods for their manufacture and use |
| US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
| US5844087A (en) | 1996-11-05 | 1998-12-01 | Bayer Corporation | Method and device for delivering fibrin glue |
| US5817381A (en) | 1996-11-13 | 1998-10-06 | Agricultural Utilization Research Institute | Cellulose fiber based compositions and film and the process for their manufacture |
| WO1998030252A1 (en) | 1997-01-09 | 1998-07-16 | Cohesion Technologies, Inc. | Methods and apparatuses for making swellable uniformly shaped devices from polymeric materials |
| US5846213A (en) | 1997-06-16 | 1998-12-08 | The University Of Western Ontario | Cellulose membrane and method for manufacture thereof |
| JP4247846B2 (ja) | 1997-07-03 | 2009-04-02 | デュピュイ・スパイン・インコーポレーテッド | 架橋ポリサッカリド薬物キャリア |
| US6162241A (en) | 1997-08-06 | 2000-12-19 | Focal, Inc. | Hemostatic tissue sealants |
| DE19813663A1 (de) | 1998-03-27 | 1999-10-07 | Beiersdorf Ag | Wundauflagen zur Entfernung von Störfaktoren aus Wundflüssigkeit |
| US6200595B1 (en) | 1998-04-24 | 2001-03-13 | Kuraray Co., Ltd. | Medical adhesive |
| US6200328B1 (en) | 1998-05-01 | 2001-03-13 | Sub Q, Incorporated | Device and method for facilitating hemostasis of a biopsy tract |
| US6056970A (en) | 1998-05-07 | 2000-05-02 | Genzyme Corporation | Compositions comprising hemostatic compounds and bioabsorbable polymers |
| US6261679B1 (en) | 1998-05-22 | 2001-07-17 | Kimberly-Clark Worldwide, Inc. | Fibrous absorbent material and methods of making the same |
| CA2350628A1 (en) | 1998-11-12 | 2000-05-18 | Polymer Biosciences, Inc. | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| US6454787B1 (en) | 1998-12-11 | 2002-09-24 | C. R. Bard, Inc. | Collagen hemostatic foam |
| US6060461A (en) | 1999-02-08 | 2000-05-09 | Drake; James Franklin | Topically applied clotting material |
| KR20010010151A (ko) * | 1999-07-16 | 2001-02-05 | 김윤 | 수용성 알긴산염과 카르복시메틸 셀룰로오스를 주성분으로 하는 유착방지제 및 그의 제조방법 |
| EP1210130A1 (en) * | 1999-08-20 | 2002-06-05 | Beaulieu, André | Solid wound healing formulations containing fibronectin |
| US6391048B1 (en) | 2000-01-05 | 2002-05-21 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
| KR100721752B1 (ko) | 2000-01-24 | 2007-05-25 | 쿠라레 메디카루 가부시키가이샤 | 수팽윤성 고분자 겔 및 그 제조법 |
| US6627785B1 (en) * | 2000-02-29 | 2003-09-30 | Virginia Commwealth University | Wound dressings with protease-lowering activity |
-
2002
- 2002-12-31 US US10/334,864 patent/US7101862B2/en not_active Expired - Fee Related
- 2002-12-31 MX MXPA04006438A patent/MXPA04006438A/es active IP Right Grant
- 2002-12-31 JP JP2003557435A patent/JP2005514105A/ja active Pending
- 2002-12-31 WO PCT/US2002/041748 patent/WO2003057072A2/en not_active Ceased
- 2002-12-31 EP EP02797532A patent/EP1469865A4/en not_active Withdrawn
- 2002-12-31 AU AU2002361902A patent/AU2002361902A1/en not_active Abandoned
- 2002-12-31 CA CA002471994A patent/CA2471994A1/en not_active Abandoned
-
2006
- 2006-02-17 US US11/357,770 patent/US20060141018A1/en not_active Abandoned
-
2007
- 2007-08-06 US US11/890,321 patent/US20080020026A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003057072A8 (en) | 2004-07-08 |
| US20080020026A1 (en) | 2008-01-24 |
| WO2003057072A3 (en) | 2003-10-30 |
| AU2002361902A8 (en) | 2003-07-24 |
| MXPA04006438A (es) | 2005-06-08 |
| WO2003057072A2 (en) | 2003-07-17 |
| US20030175327A1 (en) | 2003-09-18 |
| EP1469865A4 (en) | 2010-04-14 |
| AU2002361902A1 (en) | 2003-07-24 |
| US7101862B2 (en) | 2006-09-05 |
| EP1469865A2 (en) | 2004-10-27 |
| JP2005514105A (ja) | 2005-05-19 |
| US20060141018A1 (en) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7101862B2 (en) | Hemostatic compositions and methods for controlling bleeding | |
| EP1718147B1 (en) | Hemostatic agent for topical and internal use | |
| CA2529717C (en) | Deployable hemostatic agent | |
| US20090098193A1 (en) | Hemostatic compositions and methods for controlling bleeding | |
| JP2002513645A (ja) | 止血化合物および生体吸収性ポリマーを含む組成物 | |
| JP2004290650A (ja) | 止血用傷用包帯およびその作成方法 | |
| JP2005169103A (ja) | タンパク様ポリマーを含有している止血用傷包帯 | |
| KR101735899B1 (ko) | 의료용 생분해성 부직포 물질 | |
| US20100260845A1 (en) | Biocompatible and Biodegradable Biopolymer Matrix | |
| KR102615766B1 (ko) | 키토산 및 젤라틴을 포함하는 조직 보강용 점착 조성물 및 이의 제조방법 | |
| Xu et al. | Preparation and application of collagen-based hemostatic materials: a review | |
| AU2015301282A1 (en) | A coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating | |
| CN114832148A (zh) | 一种具有抗菌消炎功能的止血材料及制备方法与用途 | |
| RU2827960C1 (ru) | Гемостатический раствор, гемостатическое изделие и способ его изготовления |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |